ProShares UltraShort Nasdaq Biotech (BIS)

Add to Watchlists
Create an Alert
12.01 +0.17  +1.44% NASDAQ Sep 30, 3:52PM BATS Real time Currency in USD
View Full Chart
BIS Price Chart

BIS Description

ProShares UltraShort Nasdaq Biotech is a long-short equity fund managed by ProShares that tracks the NASDAQ Biotechnology TR USD index and has 73.03M USD assets under management. The fund has a net expense ratio of 0.95% and is traded on the NASDAQ.

Benchmark Index: NASDAQ Biotechnology TR USD

BIS Key Info

Expense Ratio (5-31-14) 0.95%
Assets Under Management (9-29-14) 73.03M
30-Day Average Volume (9-29-14) 440898.2
Net Asset Value (9-29-14) 11.83
Discount or Premium to NAV (9-29-14) 0.08%
Turnover Ratio --
View All BIS News
Edit Sources

BIS News

BIS Asset Allocation

Type % Net % Long % Short
Cash 299.9% 299.9% 0.00%
Stock -199.8% 0.18% 200.0%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other -0.10% 0.00% 0.10%
As of June 30, 2014

BIS Region Exposure

Americas --
North America --
Latin America --
Greater Europe --
United Kingdom --
Europe Developed --
Europe Emerging --
Africa/Middle East --
Greater Asia --
Japan --
Australasia --
Asia Developed --
Asia Emerging --
Market Classification
% Developed Markets --
% Emerging Markets --
Date Unavailable
Region breakdown data is calculated by using the long position holdings of the portfolio.

BIS Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 0.00%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of June 30, 2014

BIS Stock Market Capitalization

Giant --
Large --
Medium --
Small --
Micro --
As of June 30, 2014

BIS Top 10 Holdings

Name % Weight Price Chg %
Nasdaq Biotechnology Index Swap Societe Generale 142.6% -- --
Nasdaq Biotechnology Index Swap Bank Of America, Na 47.86% -- --
Nasdaq Biotechnology Index Swap Deutsche Bank Ag 8.75% -- --
Nasdaq Biotechnology Index Swap Credit Suisse International 0.39% -- --
Nasdaq Biotechnology Index Swap Morgan Stanley & Co. International Plc 0.18% -- --
Nasdaq Biotechnology Index Swap Morgan Stanley & Co. International Plc - Ca 0.18% -- --
Nasdaq Biotechnology Index Swap Ubs Ag 0.16% -- --
Ishares Biotech (Ibb) Swap Morgan Stanley & Co. International Plc 0.08% -- --
Nasdaq Biotechnology Index Swap Citibank, N.A. 0.04% -- --
Ishares Biotech (Ibb) Swap Bank Of America, Na 0.02% -- --
As of June 30, 2014
Get Quote for
Advertisement

BIS Risk Info

Beta -1.720
30 Day Average Volatility 38.31%

BIS Fundamentals

Dividend Yield TTM (9-30-14) 0%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio --
Weighted Average Price to Book Ratio --
Weighted Median ROE --
Weighted Median ROA --
Forecasted Dividend Yield --
Forecasted PE Ratio --
Forecasted Price to Sales Ratio --
Forecasted Price to Book Ratio --
Number of Holdings 8.000
As of June 30, 2014

BIS Growth Estimates

Forecasted 5 Yr Earnings Growth --
Forecasted Book Value Growth --
Forecasted Cash Flow Growth --
Forecasted Earnings Growth --
Forecasted Revenue Growth --
As of June 30, 2014

BIS Performance

  Returns Total Returns
1M 0.33% 0.33%
3M -15.78% -15.78%
6M -36.72% -36.72%
1Y -52.40% -52.40%
3Y -93.03% -93.03%
5Y -- --
As of Sept. 29, 2014

BIS Flows

1M 14.54M
3M 32.18M
6M 75.64M
YTD 87.45M
1Y 92.29M
3Y 100.36M
5Y --
As of Aug. 31, 2014
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.